To further explore the detailed molecular mechanism and signaling pathway by which CTHRC1 in CAFs regulates the progression of pancreatic cancer, we reviewed the literature and found that existing studies have confirmed that LIF mainly acts by activating the STAT3 signaling pathway. Here, LIF is linked to familial pancreatic carcinoma.